EmeTerm is a drug-free alternative that prevents morning sickness in pregnant women.
Up to 80% of pregnant women face the symptoms of morning sickness -- a side effect of pregnancy that induces vomiting and nausea. Women dealing with these reoccurring feelings of nausea often turn to prescription drugs, or other the counter medication to alleviate the symptoms. EmeTerm is a wearable neurotransmitter device which pulses to send signals to the brain that eliminate the possibility of nausea, before it begins. Both drug-free and non-invasive, this device effectively alleviates nausea without running the risk of birth defects.
Although developed for pregnant women, the wrist-worn device can also provide relief for those who suffer from dizzy spells or motion sickness.
Pulsing Anti-Nausea Wearables
The 'EmeTerm' Device Prevents Morning Sickness in Pregnant Women
Trend Themes
1. Anti-nausea Wearables - The development of wearable devices like EmeTerm that prevent nausea without drugs or invasive procedures.
2. Drug-free Solutions - The growing demand for drug-free alternatives to alleviate symptoms, such as morning sickness, and reduce the risk of side effects.
3. Neurotransmitter Technology - The integration of pulsing neurotransmitter devices to send signals to the brain, effectively preventing nausea before it starts.
Industry Implications
1. Maternal Health - Creating innovative solutions like EmeTerm to address the needs of pregnant women and improve their overall well-being during pregnancy.
2. Medical Devices - Developing and manufacturing wearable devices like EmeTerm that utilize advanced technology to provide non-invasive solutions for various health conditions.
3. Wellness and Personal Care - Expanding the market for drug-free solutions by offering wearable anti-nausea devices like EmeTerm for individuals experiencing symptoms like motion sickness or dizziness.